Yaşlilikta Tedavi Kilavuzu indb

YAŞLILIKTA ENDOKRİNOLOJİK HASTALIKLARIN TEDAVİ KILAVUZU
Kaynaklar
1.  AACE Menopause Guidelines, Endocr.2011;17(Suppl 6)
2.  Stuenkel CA, Davis SR, Gompel A et al. Treatment of Symptoms of the Menopause: An Endocrine Society Clinical 
Practice Guideline. J Clin Endocrinol Metab. 2015 ;100(11):3975-4011
3.  Casper RF. Clinical manifestations and diagnosis of menopause. in www.uptodate.com .2016 UpToDate.
4.  Practice bulletin no. 141: management of menopausal symptoms. Obstet Gynecol. 2014;123(1):202-16
5.  Neslihan Carda S, Bilge SA, Oztürk TN, Oya G, Ece O, Hamiyet B.The menopausal age, related factors and clima-
cteric symptoms in Turkish women. Maturitas 30 (1998) 37–40).
6.  Türkiye Menopoz ve Osteoporoz Derneği ve Türk Jinekoloji Derneği  Hormon Replasman Tedavisi Konsensus 
Grubu Kararları. Artemis, 2003; Vol 4(1) 7-8
7.  SOGC clinical practice guideline. Menopause and Osteoporosis Update 2009. JOGC 2009;31(1):1-52
8.  The 2012 Hormone Therapy Position Statement of The North American Menopause Society. Menopause. 
2012;19(3): 257–271
9.  Schenck-Gustafsson K, Brincat M, Erel CT, Gambacciani M, Lambrinoudaki I, Moen MH, Tremollieres F, Vujovic 
S, Rozenberg S, Rees M; EMAS. EMAS position statement: Managing the menopause in the context of coronary 
heart disease. Maturitas. 2011;68(1):94-7.
10.  Pérez-López FR, Brincat M, Erel CT, Tremollieres F, Gambacciani M, Lambrinoudaki I, Moen MH, Schenck-Gus-
tafsson K, Vujovic S, Rozenberg S, Rees M. EMAS position statement: Vitamin D and postmenopausal health. 
Maturitas. 2012;71(1):83-8
11.  Consensus Statement: Executive Summary of the Stages of Reproductive Aging Workshop + 10: Addressing the 
Unfinished Agenda of Staging Reproductive Aging. J Clin Endocrinol Metab. 2012 A; 97(4): 1159–1168
12.  The 2013 British Menopause Society and Women’s Heath Concern recommendations on hormone replacement 
therapy. Menopause International: The Integrated Journal of Postreproductive Health 0(0) 1–10

---

---

---

---